Objective: To evaluate trends in the use of epidural analgesia and nonopioid and opioid analgesics for patients undergoing lobectomy from 2009 to 2018.
Methods: We queried the Premier database for adult patients undergoing open, video-assisted, and robotic-assisted lobectomy from 2009 to 2018. The outcome of interest was changes in the receipt of epidural analgesia and nonopioid and opioid analgesics as measured by charges on the day of surgery. We also evaluated postoperative daily opioid use. We used multivariable logistic and linear regression models to examine the association between the utilization of each analgesic modality and year.
Results: We identified 86,308 patients undergoing lobectomy from 2009 to 2018 within the Premier database: 35,818 (41.5%) patients had open lobectomy, 35,951 (41.7%) patients had video-assisted lobectomy, and 14,539 (16.8%) patients had robotic-assisted lobectomy. For all 3 surgical cohorts, epidural analgesia use decreased, and nonopioid analgesics use increased over time, except for intravenous nonsteroidal anti-inflammatory drugs. Use of patient-controlled analgesia decreased, while opioid consumption on the day of surgery increased and postoperative opioid consumption did not decrease over time.
Conclusions: In this large sample of patients undergoing lobectomy, utilization of epidural analgesia declined and use of nonopioid analgesics increased. Despite these changes, opioid consumption on day of surgery increased, and there was no significant reduction in postoperative opioid consumption. Further research is warranted to examine the association of these changes with patient outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390760 | PMC |
| http://dx.doi.org/10.1016/j.xjon.2021.03.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Outcomes of Surgical Resection of Primary Lung Cancer After Pancreatic Cancer.
Cureus
November 2024
Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, JPN.
Objective: This study aimed to elucidate the therapeutic significance of lung resection for primary lung cancer after pancreatic cancer surgery in contemporary cases.
Methods: This retrospective cohort study included patients who had lung nodules and performed pulmonary resection after pancreatic cancer surgery at seven hospitals affiliated with the Thoracic Surgery Study Group of Osaka University between January 2009 and December 2021. Patients in which surgery was performed for biopsy purposes, those with a history of other cancers with potential for lung metastasis, patients who did not give their consent for enrollment, and patients determined to be ineligible by the attending physician were excluded from the study.
Long-term survival after sleeve lobectomy versus pneumonectomy for non-small cell lung cancer.
Surg Oncol
November 2024
Department of Cardiothoracic Surgery, Copenhagen University Hospital, 2100, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, 2200, Copenhagen, Denmark. Electronic address:
Background: To compare short-term mortality and long-term overall survival between sleeve lobectomy and pneumonectomy for centrally located non-small cell lung cancer (NSCLC).
Methods: We retrospectively reviewed patients who had been radically resected for NSCLC by sleeve lobectomy with or without pulmonary arterioplasty at our institution between 2009 and 2023. We then propensity score-matched the patients with pneumonectomy counterparts from a national registry and compared their 30- and 90-day mortality and long-term overall survival before and after matching.
Diagnosis of Respiratory Sarcopenia for Stratifying Postoperative Risk in Non-Small Cell Lung Cancer.
JAMA Surg
October 2024
Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Article Synopsis
- The study explores how respiratory sarcopenia, or reduced respiratory muscle strength, can help improve risk assessment for patients undergoing surgery for non-small cell lung cancer (NSCLC).
- Researchers analyzed data from 806 patients in Tokyo who had surgical treatment for NSCLC between 2009 and 2018, focusing on outcomes based on their levels of respiratory strength and muscle mass.
- Findings indicate that respiratory strength is a better predictor of patient outcomes than the traditional metric of muscle radiodensity, suggesting that factoring in respiratory sarcopenia could enhance postoperative care strategies.
Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial.
J Thorac Oncol
October 2024
JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Article Synopsis
- The JCOG0802/WJOG4607L trial showed segmentectomy is better than lobectomy for overall survival in small-peripheral non-small-cell lung cancer, but locoregional relapse (LR) is still a concern.
- An analysis of 1105 patients with various tumor sites determined that factors like solid tumor appearance and close margins significantly increased the risk of LR after segmentectomy.
- Key findings stress the importance of using thin-section CT scans and ensuring sufficient margin distance to minimize the risk of LR in patients undergoing segmentectomy.
The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective Analysis.
Cancers (Basel)
June 2024
Division of Vascular and Interventional Radiology, Department of Radiological Sciences, University of California Irvine, Orange, CA 92868, USA.
Y-90 Selective Internal Radiotherapy (SIRT) is an ablative therapy used for inoperable liver metastasis. The purpose of this investigation was to examine the impact of local control after SIRT on overall survival (OS) in oligometastatic patients. A retrospective, single-institution study identified oligometastatic patients with ≤5 non-intracranial metastases receiving unilateral or bilateral lobar Y-90 SIRT from 2009 to 2021.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!